Amazentis

Lausanne, CH · 2 known investors

Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy. It brings the molecule to consumers through its Timeline brand of supplements and skincare, and partners with companies including Nestlé Health Science and L'Oréal.

BiotechLongevityWellness & Fitness